models to humans, and that heterogeneity in the patient population presents a significant 28 challenge. Here, we summarize both successful and failed experiences in anticancer 29 development during the past 20 years and help identify why the paradigm may be suboptimal. 30 We also offer potential strategies for improvement.
32
Current progress of anticancer drug development 33 Cancer, which is characterized by uncontrolled growth of cells in the body, is one of the most 34 difficult and complex diseases to treat [1] [2] [3] . Cancer patients suffer high mortality rates, which Additionally, the human cancer cell line is typically extracted from early-stage cancer patients. Figure   461 4).
462

Precision medicine
463
Precision medicine is an approach to integrate molecular and clinical information to better 
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